IDEXX Laboratories Inc. (NASDAQ: IDXX) reported better-than-expected fourth-quarter financial results and issued a fiscal 2026 forecast on Monday.
Detailed price information for Idexx Laboratories (IDXX-Q) from The Globe and Mail including charting and trades.
Investor's Business Daily on MSN
IDEXX tumbles following an 'impressive' report; can it shake pet-health challenges?
Idexx stock fell Monday despite beating fourth-quarter expectations and issuing strong guidance for 2026.
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q4 2025 Earnings Call Transcript February 2, 2026 IDEXX Laboratories, Inc. beats ...
IDEXX Laboratories (NASDAQ:IDXX) reported double-digit fourth-quarter growth and laid out its initial 2026 outlook, ...
Feb 2 (Reuters) - Animal diagnostics maker IDEXX Laboratories on Monday forecast 2026 revenue and profit above Wall Street estimates, betting that resilient demand at veterinary clinics and higher ...
Ahead of Q4 earnings, IDXX eyes double-digit revenue and EPS growth, driven by CAG momentum, new diagnostics and steady Water ...
The Q4 earnings report for IDEXX Laboratories (NASDAQ: IDXX) was released on Monday, February 2, 2026 at 06:30 AM. Here's ...
Q4 2025 earnings call highlights: 2026 guidance, CAG Diagnostics growth, inVue Dx/Cancer Dx momentum, margins & risks—read now.
Detailed price information for Idexx Laboratories (IDXX-Q) from The Globe and Mail including charting and trades.
IDXX tops Q4 EPS and revenue estimates as margins expand. However, shares dip during the pre-market trading, while 2026 ...
While they might not represent the most exciting field in the biotech space, animal healthcare companies have been a steady, consistent source of growth in what's often a turbulent market. One company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results